4.4 Article

The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013)

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.urolonc.2017.10.023

Keywords

Prostatic neoplasms; United States; Epidemiology; Neoplasm metastasis

Funding

  1. National Institutes of Health, United States [5U01CA196390]

Ask authors/readers for more resources

Background: Understanding the characteristics of men who initially present with metastatic prostate cancer (mPCa) can better enable directed improvement initiatives. The objective of this study was to assess the relationship between socioeconomic status (SES) and newly diagnosed mPCa. Materials Methods: All men diagnosed with PCa in the National Cancer Data Base from 2004 to 2013 were identified. Characteristics of men presenting with and without metastatic disease were compared. A 4-level composite metric of SES was created using Census-based income and education data. Multivariable logistic regression was used to evaluate the association between SES, race/ethnicity, and insurance and the risk of presenting with mPCa at the time of diagnosis. Results: Of 1,034,754 patients diagnosed with PCa, 4% had mPCa at initial presentation. Lower SES (first vs. fourth quartile; odds ratio [OR] = 1.39, 95% CI: 1.35-1.44), black and Hispanic race/ethnicity (vs. white; OR = 1.47, 95% CI: 1.43-1.51 and OR = 1.22, 95% CI: 1.17-1.28, respectively), and having Medicaid or no insurance (vs. Medicare or private; OR = 3.91, 95% CI: 3.78-4.05) were each independently associated with higher odds of presenting with mPCa after adjusting for all other covariates. Conclusions: Lower SES, race/ethnicity, and having Medicaid or no insurance were each independently associated with higher odds of presenting with metastases at the time of PCa diagnosis. Our findings may partially explain current PCa outcomes disparities and inform future efforts to reduce disparities. (c) 2018 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Urology & Nephrology

Perceptions of the Link between Smoking and Bladder Cancer among United States Adults

Akya K. Myrie, Richard S. Matulewicz

JOURNAL OF UROLOGY (2021)

Article Urology & Nephrology

Patterns of Current Cigarette Smoking, Quit Attempts and Cessation Counseling among Survivors of Smoking-Related and Nonsmoking-Related Urological Malignancies: A Nationally Representative Cross-Sectional Analysis

Richard S. Matulewicz, Ramsankar Basak, Ibardo Zambrano, Bianca A. Dearing, Daniel Schatz, Omar El Shahawy, Scott Sherman, Marc A. Bjurlin

Summary: Among survivors of genitourinary cancers, those with a reported history of smoking-related cancers had a higher prevalence of current cigarette smoking and reported more frequent receipt of smoking cessation counseling, but did not attempt to quit smoking any more often.

JOURNAL OF UROLOGY (2021)

Editorial Material Andrology

Urologist-led smoking cessation: a way forward through implementation science

Richard S. Matulewicz, Danil V. Makarov, Scott E. Sherman, Sarah A. Birken, Marc A. Bjurlin

TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)

Article Oncology

Patterns and associations of smoking and electronic cigarette use among survivors of tobacco related and non-tobacco related cancers: A nationally representative cross-sectional analysis

Marc A. Bjurlin, Ramsankar Basak, Ibardo Zambrano, Daniel Schatz, Omar El Shahawy, Scott Sherman, Richard S. Matulewicz

Summary: The study found that survivors of tobacco-related cancers have a significantly higher prevalence of cigarette smoking and e-cigarette use compared to survivors of non-tobacco related cancers. The prevalence of smoking among all survivors increased each subsequent year from the time of new cancer diagnosis, highlighting the need for long-term tobacco cessation support for newly diagnosed adults with cancer.

CANCER EPIDEMIOLOGY (2022)

Review Urology & Nephrology

A Systematic Review and Scoping Analysis of Smoking Cessation after a Urological Cancer Diagnosis

Calvin Zhao, Marc A. Bjurlin, Timothy Roberts, Michael Rink, Shahrokh F. Shariat, Richard S. Matulewicz

Summary: This study found that there is a low smoking cessation rate among urological cancer patients after diagnosis, and there is a lack of support from urologists in helping patients quit smoking.

JOURNAL OF UROLOGY (2021)

Article Oncology

Using a multilevel implementation strategy to facilitate the screening and treatment of tobacco use in the outpatient urology clinic: A prospective hybrid type I study

Richard S. Matulewicz, Jeffrey C. Bassett, Lorna Kwan, Scott E. Sherman, William J. McCarthy, Christopher S. Seigal, John L. Gore

Summary: A strategy that includes provider education and a customized clinical decision support tool can facilitate provider use of evidence-based practices for tobacco cessation in a urology clinic.

CANCER (2022)

Review Oncology

Carcinogenic biomarkers of exposure in the urine of heated tobacco product users associated with bladder cancer: A systematic review

Christopher Svendsen, Andrew James, Richard S. Matulewicz, Elizabeth Moreton, Roman Sosnowski, Scott Sherman, Ilona Jaspers, Terry Gordon, Marc A. Bjurlin

Summary: This study aims to identify biomarkers of exposure associated with bladder cancer in heated tobacco product (HTP) users' urine. The findings showed that biomarkers of exposure to bladder carcinogens are present in the urine of HTP users, although at lower levels than combustible cigarette users. Further long-term study is needed to determine the bladder cancer risk of HTP use.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Article Oncology

Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with blue light cystoscopy

Richard S. Matulewicz, Kourosh Ravvaz, John A. Weissert, Sima Porten, Gary D. Steinberg

Summary: The study found no significant association between smoking status and recurrence in a cohort primarily consisting of high-risk recurrent NMIBC patients. The results suggest that smoking may not play a significant role in the recurrence of non-muscle invasive bladder cancer.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Article Oncology

Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancer

Giovanni E. Cacciamani, Richard S. Matulewicz, Raj Kumar, Jeremy Yuen-Chun Teoh, Andrea Mari, Benjamin Pradere, Juan Gomez Rivas, Andrea Necchi, Sumanta Kumar Pal, Maria J. Ribal, Shahrokh Shariat, Michael Rink

Summary: The association between tobacco use and urothelial cancer of the bladder is well known. Interventions for urologists and other professionals should be made to address this issue. Awareness of contemporary checkpoints for intervention may aid medical education in challenging tobacco epidemic settings.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Editorial Material Urology & Nephrology

Assessment of Tobacco Screening and Smoking Cessation Recommendations among Bladder Cancer Guidelines: A Call to Action

Jamie Michael, Richard S. Matulewicz, Marc A. Bjurlin

JOURNAL OF UROLOGY (2022)

Article Oncology

Clinical-Bladder cancer Machine learning decision support model for radical cystectomy discharge planning

Calvin C. Zhao, Marc A. Bjurlin, James S. Wysock, Samir S. Taneja, William C. Huang, David Fenyo, Richard S. Matulewicz

Summary: The purpose of this study was to improve the discharge planning process by creating a machine learning model that predicts the need for non-home hospital discharge. The model showed strong performance in identifying patients who required higher levels of care, outperforming commonly used clinical indices and prior work.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Article Oncology

Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute-Designated Cancer Centers

Sarah D. Hohl, Richard S. Matulewicz, Ramzi G. Salloum, Jamie S. Ostroff, Timothy B. Baker, Robert Schnoll, Graham Warren, Steven L. Bernstein, Mara Minion, Katie Lenhoff, Neely Dahl, Hee Soon Juon, Ursula Tsosie, Linda Fleisher, Heather D'Angelo, Alex T. Ramsey, Kimlin T. Ashing, Betsy Rolland, Margaret B. Nolan, Jennifer E. Bird, Claire V. T. Nguyen, Danielle Pauk, Robert T. Adsit, Hilary A. Tindle, Kimberly Shoenbill, Sophia Yeung, Cary A. Presant, Kara P. Wiseman, Kuang-Yi Wen, Lou-Anne Chichester, Li-Shiun Chen

Summary: The C3I program found that implementing comprehensive tobacco treatment programs and improving the staff-to-patient ratio can increase the reach of cessation treatment. Strengthening the tobacco treatment team and providing more resources can improve the effectiveness of smoking cessation.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Smoking cessation pharmacotherapy use during index hospital admission following cystectomy for bladder cancer: A retrospective cohort study

Eli Rapoport, Marc A. Bjurlin, Helena Furberg, Timothy F. Donahue, Samir S. Taneja, Bernard H. Bochner, Jamie S. Ostroff, Richard S. Matulewicz

Summary: This study aimed to assess gaps in urologic oncology quality and evidence-based smoking cessation care after cystectomy, and found that the proportion of patients receiving smoking cessation pharmacotherapy was low and varied. Factors such as age, race, and patient comorbidity score were associated with the likelihood of receiving smoking cessation pharmacotherapy. The findings indicate inadequate urologic oncology care and missed opportunities for effective intervention in bladder cancer surgery patients.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2023)

Article Urology & Nephrology

Urologists' Perceptions and Practices Related to Patient Smoking and Cessation: A National Assessment From the 2021 American Urological Association Census

Richard S. Matulewicz, William Meeks, Rachel Mbassa, Raymond Fang, Ashley Pittman, Matthew Mossanen, Helena Furberg, Lou-Anne Chichester, Michelle Lui, Scott E. Sherman, Danil Makarov, Marc A. Bjurlin, Jamie S. Ostroff

Summary: This study aimed to assess urologists' perceptions and practices related to smoking and smoking cessation. The results of the survey showed that most urologists recognized the significant contribution of cigarette smoking to urologic disease, but there was a low level of agreement on the importance of tobacco use assessment and treatment in urology clinics. Furthermore, when advising patients who smoke, urologists tended to not provide additional counseling or medications and faced various barriers such as lack of time, patient unwillingness to quit, and discomfort in prescribing cessation medications.

UROLOGY (2023)

Article Urology & Nephrology

Toward the Deimplementation of Computed Tomography Urogram for Patients With Low- to Intermediate-risk Microscopic Hematuria: A Mixed-method Study of Factors Influencing Continued Use

Sarah A. Birken, Richard Matulewicz, Ram Pathak, Cheyenne R. Wagi, Alexandra G. Peluso, Richa Bundy, Lauren Witek, Bridget Krol, Michael L. Parchman, Matthew Nielsen, Ajay Dharod

Summary: This study aimed to investigate the factors contributing to the continued use of low-value CT urogram after guideline revision. The study used a mixed-method design, utilizing electronic health record data and semi-structured interviews, to examine the determinants of low-value CT urogram at a single academic tertiary medical center in the southeastern United States. The findings suggest that provider awareness of the revised guidelines, clinical judgment, and external influences play a role in the use of low-value CT urogram.

UROLOGY PRACTICE (2023)

No Data Available